here are 4 mass. biotechs making noise at the ash conference so far
.
when robert had to go on full medical disability in his early 50s after hurting himself at work, helen went back to work, this time in the oil industry.
.
.
.
.
.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.